Pharmaust Ltd. | Income Statement
Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
1,880.80
1,869.20
2,017.90
2,854.20
2,871.30
Cost of Goods Sold (COGS) incl. D&A
2,000.90
2,465.30
2,121.10
2,986.70
3,969.90
Gross Income
120.10
596.10
103.20
132.50
1,098.50
SG&A Expense
1,320.30
1,876.30
2,449.40
1,631.10
1,819.30
EBIT
1,441.50
2,472.40
2,552.50
1,763.60
2,917.90
Unusual Expense
-
-
2,071.70
-
-
Non Operating Income/Expense
58.60
502.10
700.00
453.40
424.60
Interest Expense
2.70
3.60
39.90
59.40
28.40
Pretax Income
1,317.90
1,925.10
3,927.30
1,343.60
2,521.70
Consolidated Net Income
1,317.90
1,925.10
3,927.30
1,343.60
2,521.70
Net Income
1,317.90
1,925.10
3,927.30
1,343.60
2,521.70
Net Income After Extraordinaries
1,317.90
1,925.10
3,927.30
1,343.60
2,521.70
Net Income Available to Common
1,317.90
1,925.10
3,927.30
1,343.60
2,521.70
EPS (Basic)
0.02
0.02
0.01
0.01
0.02
Basic Shares Outstanding
69,173.80
78,772.10
682,691.70
124,566.00
-
EPS (Diluted)
0.02
0.02
0.01
0.01
-
Diluted Shares Outstanding
69,173.80
78,772.10
682,691.70
124,566.00
-
EBITDA
1,388.10
2,395.20
2,443.30
1,640.50
2,799.30
Other Operating Expense
1.10
-
-
-
-
Non-Operating Interest Income
67.70
48.70
36.80
25.90
-
About Pharmaust
View Profile
